Project
CLDK378
Automatically Closed · 2013 until 2015
Früh Martin, Munz Jeannine, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2013
End Date
2015
Financing
Industry
Labels
lung cancer
Brief description/objective
A phase III, multicenter, randmozed, open-label study of oral LDK378 versus standard chemotherapy in adult patients with ALK-rearranged (ALK-positive) advanced non-small cell lung cancer who have been treated previously with chemotherapy (platinum doublet) and crizotinib, Protokoll CLDK378A2303, Novartis